Beta thalassemia
1 paper
Trial sponsors
Novartis Pharmaceuticals Corporation
Company1 trialPhase 3595 people
Azienda Ospedaliera V. Cervello
1 trialPhase 4213 people
Royal Brompton & Harefield NHS Foundation Trust
1 trialPhase 465 people
1 trialPhase 366 people
2 trialsPhase 2/3738 people
Tehran University of Medical Sciences
1 trialPhase 2/350 people
National Heart, Lung, and Blood Institute
3 trialsPhase 270 people
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan
2 trialsPhase 254 people